Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Genome-wide association study of endometrial cancer in E2C2.
Authors: De Vivo I,  Prescott J,  Setiawan VW,  Olson SH,  Wentzensen N,  Australian National Endometrial Cancer Study Group,  Attia J,  Black A,  Brinton L,  Chen C,  Chen C,  Cook LS,  Crous-Bou M,  Doherty J,  Dunning AM,  Easton DF,  Friedenreich CM,  Garcia-Closas M,  Gaudet MM,  Haiman C,  Hankinson SE,  Hartge P,  Henderson BE,  Holliday E,  Horn-Ross PL,  Hunter DJ,  Le Marchand L,  Liang X,  Lissowska J,  Long J,  Lu L,  Magliocco AM,  McEvoy M,  O'Mara TA,  Orlow I,  Painter JN,  Pooler L,  Rastogi R,  Rebbeck TR,  Risch H,  Sacerdote C,  Schumacher F,  Scott RJ,  Sheng X,  Shu XO,  Spurdle AB,  Thompson D,  Vanden Berg D,  Weiss NS,  Xia L,  Xiang YB,  Yang HP,  Yu H,  Zheng W,  Chanock S,  Kraft P
Journal: Hum Genet
Date: 2014 Feb
Branches: EBP, MEB, LGS, OD, OEEB
PubMed ID: 24096698
PMC ID: PMC3898362
Abstract: Endometrial cancer (EC), a neoplasm of the uterine epithelial lining, is the most common gynecological malignancy in developed countries and the fourth most common cancer among US women. Women with a family history of EC have an increased risk for the disease, suggesting that inherited genetic factors play a role. We conducted a two-stage genome-wide association study of Type I EC. Stage 1 included 5,472 women (2,695 cases and 2,777 controls) of European ancestry from seven studies. We selected independent single-nucleotide polymorphisms (SNPs) that displayed the most significant associations with EC in Stage 1 for replication among 17,948 women (4,382 cases and 13,566 controls) in a multiethnic population (African America, Asian, Latina, Hawaiian and European ancestry), from nine studies. Although no novel variants reached genome-wide significance, we replicated previously identified associations with genetic markers near the HNF1B locus. Our findings suggest that larger studies with specific tumor classification are necessary to identify novel genetic polymorphisms associated with EC susceptibility.